NASDAQ:CCXI
Delisted
ChemoCentryx Stock News
$51.99
+0 (+0%)
At Close: Jan 27, 2023
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
10:35pm, Monday, 05'th Jul 2021
New York, New York--(Newsfile Corp. - July 5, 2021) - Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investor
CCXI LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving ChemoCentryx, Inc.
06:18pm, Monday, 05'th Jul 2021
New York, New York--(Newsfile Corp. - July 5, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased ChemoCentryx, Inc. ("Chemo
New York, New York--(Newsfile Corp. - July 5, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ChemoCentryx, Inc. (NASDAQ: CCXI) alleging
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for ChemoCentryx, Inc. Investors - CCXI
10:10am, Monday, 05'th Jul 2021
RADNOR, Pa., July 5, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. (NASDAQ: C
New York, New York--(Newsfile Corp. - July 5, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Che
Biotech Losers In 2021 That Could Bounce Big In The Second Half
05:02pm, Saturday, 03'rd Jul 2021
Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off entirely nor picked a
RADNOR, Pa.--(BUSINESS WIRE)---- $CCXI #classaction--CCXI DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of ChemoCentryx, Inc. of Deadline in Securities Fraud Class Action Lawsuit
Radnor, Pennsylvania--(Newsfile Corp. - July 2, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against ChemoCe
New York, New York--(Newsfile Corp. - July 2, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ChemoCentryx, Inc. ("ChemoCentryx" or "th
Is It Too Late to Buy ChemoCentryx Stock?
09:32am, Friday, 02'nd Jul 2021
This biotech is traveling in uncharted waters.
Los Angeles, California--(Newsfile Corp. - July 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. ("
New Orleans, Louisiana--(Newsfile Corp. - July 1, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have un
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ChemoCentryx, Inc. (CCXI) Investors
11:05am, Thursday, 01'st Jul 2021
LOS ANGELES, July 1, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired
Los Angeles, California--(Newsfile Corp. - July 1, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc.
New York, New York--(Newsfile Corp. - June 30, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
